In an effort to elucidate the mechanism by which indomethacin (IN) lessens the stimulatory effect of estradiol (E 2 ) on rabbit splenic red pulp macrophages (RPMs), 39 female New Zealand White rabbits were divided into 10 groups: ovariectomized (OVX) and OVX/ IN at 0.1 and 5.0 mg/kg body weight (bw)/day; sham OVX (SOVX) and SOVX/IN at 0.1 and 5.0 mg/kg bw/day; OVX/25 mg E 2 and OVX/25 mg E 2 /IN at 0.1 and 5.0 mg/kg bw/day; and intact control. Changes in RPM population in response to treatment were measured using a 0-4 histologic grade. Estradiol treatment resulted in increased RPM grade when compared to the OVX groups. Indomethacin addition lowered mean RPM grade in the SOVX/IN 5.0 group when compared to its E 2 control group. Indomethacin administration had no significant effect on levels of prostaglandin E 2 in spleen, urine, or blood. Hematocrits were reduced in both OVX and OVX/E 2 groups; this decrease was exacerbated by the high IN dose. In summary, the results from this study suggest that the effect of IN on E 2 -induced RPM activation may be mediated through a nonprostaglandin pathway. The observed hematocrit changes are possibly the result of direct action of IN and E 2 on erythrocytes, resulting in their accelerated clearance from the circulation by splenic RPM.
INTRODUCTION
Changes in monocytic phagocyte numbers and phagocytic activity in response to variations in estrogenic hormone levels have been reported in mice and rats by several researchers (7, 8, 25, 27) . In general, these investigators noted that monocytic phagocyte numbers and phagocytic activity decreased when estrogen levels were below physiologic levels (i.e. after ovariectomy) and increased during the follicular and luteal phases and during pregnancy or when estrogen supplementation was administered. An increase in number and activity of macrophages was also observed when the synthetic estrogen diethylstilbestrol was administered to female mice (9) . Although the macrophage immunostimulatory effects of estrogens have been documented, as of yet little is known about the mechanism of activation.
A similar change in monocytic phagocyte number and activity was noted in our laboratory when 25-mg 17(3estradiol (E2) sustained-release pellets were subcutaneously implanted in ovariectomized (OVX) New Zealand White (NZW) rabbits. Hyperplasia and hypertrophy of splenic red pulp macrophages (RPMs) were observed after a period of 3 wk (37) . In a study by Coogan et al, E2 administration continued for as long as a year was found to also produce hyperplasia of renal medullary interstitial cells (14) . Since both cell types involved in these changes are sources of prostaglandin E, (PGE,), a study was conducted administering the nonsteroidal antiinflammatory cyclooxygenase blocker indomethacin (IN) along with E, to determine whether the observed RPM effects may be related to their production of this arachidonic acid metabolite. The IN was administered to E,-supplemented (3wk sustained-release, 25-mg subcutaneous pellets), specific pathogen-free (SPF), ovariectomized NZW rabbits as 3-wk sustained-release subcutaneously implanted pellets in doses of 1.0, 10.0, and 13.0 mg/kg body weight (bw)/day. Results of this 21-day study showed that the 2 larger IN doses were effective in reducing the extent of splenic RPM hyperplasia and hypertrophy when compared to the spleens of rabbits receiving E2 alone and E2 plus the low dose of IN (unpublished data). Based on the results of this pilot study, a 3-way crossover study utilizing 3 treatment regimens was undertaken to further investigate the mechanism of estradiol supplementationproduced splenomegaly and to gain insight into IN's actions on inhibition of the splenic macrophage changes.
MATERIALS AND METHODS
Drugs and Analytical Reagents. Three-wk constantdose-release IN and E, pellets were obtained from Innovative Research (Toledo, OH). Tritium-labeled PGE2 ( [5, 6, 8, 11, 12, 14, 15 -3H]-PGE2) for determining PGE2 recovery after tissue extraction was obtained from the New England Nuclear division of Dupont (Wilmington, DE).
Animals. Animals for this study were sexually mature (mean weight 3.45 ± 0.23), SPF, female NZW rabbits obtained from Myrtle's Rabbitry (Franklin, TN). All rabbits were kept in isolation for 1 wk prior to the start of the experiment. Housing and care was in accordance with National Institutes of Health and U.S. Department of Agriculture guidelines.
Experimental Design. Thirty-nine rabbits were randomly assigned to 9 treatment groups of 4 animals each and a tenth control group (nontreated, intact control) of 3 animals. The treatment groups were as follows: (a) ovariectomized control (OVX control), (b) OVX (5.0 mg/kg bw/day) IN dose used in this study was chosen to reduce the possibility of overt toxicity observed in some animals at the higher doses used in the previous study.
On the initial day of study, all OVX treatment group animals were anesthetized, ovariectomized, and implanted subcutaneously with 3-wk constant-dose-release pellets containing either IN or E2, or both pellet types. The ovaries of the SOVX groups were manipulated and replaced at the time of drug implantation.
All animal-use experimental protocols were approved by the East Tennessee State University Committee on Animal Care.
Necropsy. At the end of the 21-day study period, body weights, blood smears, and hematocrits were again obtained. All animals were then euthanized using an overdose of pentobarbital sodium and necropsied. At necropsy, gross pathologic changes were noted and samples of blood, urine, spleen, and bone were taken for further analyses.
Histopathology. Sections of spleen were fixed in 10°~0 neutral phosphate-buffered formalin (NBF), routinely processed, and paraffin-embedded. Sections were cut at 5 j.1m and stained with hematoxylin and eosin (H&E). Slides were evaluated blindly for splenic red pulp changes by 2 independent evaluators. Changes in RPM populations were graded using a 0-4 grading scale, with 0 indicating minimal numbers of RPMs and 4 indicating marked numbers of RPMs.
Sections of rib bone for marrow evaluation were taken from the costal-chondral region, fixed in NBF, and decalcified in a mixture of 40% formic acid and Amberlite IR-120 P ion exchange resin (Sigma Chemical Co., St. Louis, MO) for at least 24 hr. Following decalcification, the specimens were routinely processed for histology and stained with H&E stains. Bone marrow evaluations were based on observed changes in overall cellularity, changes in megakaryocyte numbers, and changes in numbers of myelocyte and erythrocyte precursors. Observed changes were graded from 0 to 4, with 0 indicating minimal cellularity or cell numbers and 4 indicating marked cellularity or cell numbers. Hematology. Microhematocrits were determined prior to the beginning of the study and at 21 days using the procedure of Strumia et al (34) .
PGE2 Assays. Samples of blood, urine, and spleen for PGE2 analyses were collected in silicon-coated test tubes containing IN [25 j.1g/ml dissolved in ethanol and added to phosphate-buffered saline (PBS)]. The urine and blood samples were then frozen at -80°C while the spleen samples were homogenized in PBS and then frozen. PGE2 levels were determined using an acetylcholine esterase enzyme immunoassay detection system (ACE@-EIA) (Cayman Chemical Co., Ann Arbor, MI). Urine samples were assayed directly while blood samples and spleen homogenates were purified by the solid-phase extraction procedure recommended by Cayman Chemical (Prostaglandin E2 Enzyme Immunoassay Kit manual).
Statistical Analyses. Statistical analyses of the results of this study were done using the paired t-test to compare pretreatment and 21-day results and a 1-way analysis of variance with a Duncan new multiple-range post-hoc test, or a Kruskal-Wallis test for nonparametric grading results, to evaluate intergroup significance. An a level of 0.05 was set for determining significance. Statistics were performed using either the StatVie TM II (Abacus Concepts, Inc., Berkeley, CA) or SuperANOVATM (Abacus Concepts) computer software package.
RESULTS

,
PGE2 Analyses
Results for PGE2 assays are shown in Table I . PGE2 levels ranged between 211.2 pg/ml (mean nontreated, intact control values) and 434.1 pg/ml (mean SOVX/IN 5.0 values) for urine samples, 1.43 ng/ml (mean OVX/EZ/IN 5.0 values) and 1.79 ng/ml (mean OVX/C values) for spleen homogenates, and 53.3 pg/ml (mean nontreated, intact control values) and 512.8 pg/ml (mean OVX/C values) for blood. None of the group mean PGE2 levels were significantly different for any of the tissues examined.
Hematocrits
The pretreatment mean hematocrits for each group ranged between 39 and 45%. The 21-day mean values ranged between 36% for the OVX/EZ/IN 5.0 group and 41 to for the SOVX/C group. IN treatment at 5.0 mg/kg bw/day resulted in a significantly (p < 0.05) reduced 21- day mean hematocrit in the OVX group (Fig. 1 ). Estradiol supplementation also resulted in reduced mean 21day hematocrits and addition of IN at 5.0 mg/kg bw/day exacerbated the E2 effect. The decrease in mean 21-day hematocrit observed in the OVX control group may be the result of surgery-related trauma.
Histology
Blind evaluations in grading for splenic RPM population and bone marrow changes for the 2 evaluators were strongly in agreement with correlations ranging between r = 0.843 and 0.944. The strongest correlation occurred in the evaluation of RPM grade with an r value of 0.944. Results for splenic RPM and bone marrow evaluations for both evaluators, along with correlation coefficients, are shown in Table II. Splenic RPM Evaluations. Representative histologic sections for each RPM grade are shown in Fig. 2A -D. Grade 0 spleen red pulps were characterized by narrow venous sinuses and splenic cords ( Fig. 2A ). As the grade increased from 0 to 4, the architecture became distorted with the splenic cords becoming increasingly thick due to the increased number of RPMs. The RPMs were observed to form small solid clusters of macrophages at the higher intermediate grades (Fig. 2C ) and ultimately formed sheets of cells at Grade 4 (Fig. 2E ). The venous sinuses became less structurally distinct as grade increased, although occasional dilated sinuses were observed in some sections at higher transitional grades (Fig.  2D) . By Grade 4, few well-defined venous sinuses were seen ( Fig. 2E ).
Ovariectomy produced an overall significant decrease (p < 0.05) in numbers of splenic cord RPMs when comparison was made to the SOVX and E2-supplemented treatment regimens and to the intact control group. Supplementation with E2 increased the density of RPMs over that of the OVX regimen, although not to a level that was significantly greater than that of the intact control group. The addition of IN was effective in decreasing the RPM population in the SOVX/IN 5.0 group when compared to its respective control in the OVY,/E2 treatment regimen (OVX/E2/IN 5.0) ( Fig. 3) .
Bone Marrow Evaluations. No significant differences were found among any of the groups in evaluations of overall bone marrow cellularity, numbers of erythroid precursors, myeloid precursors, or megakaryocytes.
DISCUSSION
The changes in the rabbit splenic RPM populations observed in this study are similar to those seen in our previous study in that animals in the ovariectomized non-E2-Supplemented groups had decreased numbers of macrophages when compared to the ovariectomized E2-SUPplemented control group (37) . Although the stimulatory effect of estrogens on macrophages has been well documented, little is known about how they produce this effect. The likelihood of a direct E2 involvement in macrophage activation is given credence by the demonstration of estrogen receptors in human peripheral monocytes (36) and in the J 111 human monocytic leukemia cell line and rat peritoneal macrophages (19) . One of the major cytokines produced by activated macrophages is interleukin 1 (IL-1), which may serve to indirectly stimulate further macrophage proliferation either via induction of Tlymphocyte production of interleukin 3 or granulocyte/ TABLE II.-Histopathology grading scores and correlation coefficients for both evaluators for bone marrow variables and splenic RPMs (mean ± SEM). a n = 4 for all groups except for intact control, where n = 3. macrophage colony-stimulating factor (GM-CSF) (13) or by stimulating GM-CSF or macrophage colony-stimulating factor production by fibroblasts and endothelial cells (4) . Murine peritoneal macrophages have been shown to produce IL-1 in response to physiological and pharmacologic levels of E2 (5, 17) . Estradiol treatment of peripheral blood mononuclear cells from healthy men also stimulated increased secretion of IL-1 (26). Conflicting results have been shown in the work of Pacifici et al (28) , who reported increased IL-1 activity in the medium derived from monocyte cultures obtained from untreated postmenopausal women versus the medium from either untreated premenopausal or estrogen/progesterone-treated postmenopausal women. Sato et al (31) also reported that estrogen treatment of lipopolysaccharide-stimulated macrophages from oophorectomized rats inhibited the release of IL-l. These contradictory findings for E2's effect on IL-1 production indicate that further evaluation of its potential role is required. Phagocytosis mediated by Fc&dquo;! receptors (FcRs), which recognize the F, region of the IgG molecule, and complement receptors (CRs), which bind the C3b and C3bi fractions of complement, are the primary mechanism of macrophage removal of antigen-antibody complexes (recognized by FcRs) and opsonized particles (recognized by CRs) from the circulation. A possible direct action of E2 on this phagocytic process has been reported by Schreiber et al (32) , who noted that estrogens enhanced splenic macrophage F~R-dependent clearance of IgGcoated erythrocytes. Baranao et al (6) further demonstrated that ovariectomy decreased the functionality of mouse peritoneal macrophage membrane receptors involved in the CR-mediated phagocytosis of Candida albicarcs. This membrane receptor functionality was restored by estradiol supplementation.
Contrary to the findings of our previous study, addition of indomethacin to E2-supplemented animals did not produce a reduction in the RPM population; however, IN administration did produce a significant decrease in RPM grade in the SOVX/IN 5.0 group when compared to its OVXlE2/IN 5.0 control group. This significance of effect of the high dose of IN in the SOVX groups and not in the E,-supplemented group may represent a dose-response relationship in that the lower dose used in this study was not sufficient to overcome the immunostimulatory effect of a pharmacologic level of E, but was sufficient to have an effect at normophysiologic E, levels.
One of the major mediators of macrophage phagocytic activity is considered to be PGE2 (2) . Release of PGE2 from activated macrophages is usually followed by suppression of further activation, and blockage of PGE2 production increases macrophage activity. Because the decrease in RPM population in the SOVX/IN 5.0 group was not accompanied by a significant change in mean PGE2 level, the IN-induced effect may not be prostaglandin mediated but may involve a direct action of IN on the RPMs. Several authors have demonstrated that IN administration can have an effect on cell membranes without mediating a change in prostaglandin levels. Rice et al (30) , in their investigations on liver plasma membranes of Sprague-Dawley rats, showed that IN administered in vivo directly reduced the binding affinity of PGE2 without having an effect on PGE2 levels (30) . Razin et al (29) , in their research on mouse peritoneal macrophages, noted that in vitro IN treatment produced a significant decrease in membrane binding of IgG-coated sheep erythrocytes and a significant increase in the binding of cationized ferritin.
IN administration in vitro has also been shown to stabilize mouse peritoneal macrophage lysosomal membranes independent of its effect on prostaglandin production (16) . In addition, formyl-methionine-leucine-phenylalanine-induced aggregation of polymorphonuclear leukocytes is also blocked by IN via a nonprostaglandin-related pathway (1) .
An interesting finding in our investigations was the significant decrease in the 21-day mean hematocrit observed in the OVX control and OVX/IN 5.0 groups and in all the OVX groups receiving E2 supplementation. This reduction in hematocrit was more pronounced in the groups that received the high IN dose. Both IN and E2 have been linked to the induction of aplastic anemia. Aplastic anemia resulting from estrogen administration and characterized by bone marrow hypoplasia has been reported in the dog (33) and rat (35) . Indomethacin administration has been linked to aplastic anemia in humans (24) . A single case of IN administration-related pure red cell aplasia was reported by Burghuber (12) . Evaluation of the bone marrow sections in our study failed to detect any significant differences in overall cellularity or numbers of erythroid precursors, indicating that the observed hematocrit changes are probably not due to decreases in blood cell production. While the hematocrit changes in the OVX control group could be attributed to a response to surgical trauma, in the other groups a more likely explanation for the decrease may be related to direct action of both IN and E2 on erythrocyte plasma membranes. Both E2 and IN have been shown to produce changes in erythrocyte plasma membranes. Red blood cells from women who used ethinyl E2-based birth control pills were found to have reduced membrane fragilities (21) . Estrogenic compounds were also found to block uptake of monosaccharides as well as decrease the membrane integrity of human red cells in vitro (22) . Addition of IN to washed canine red blood cells resulted in increased membrane stability, as determined by increased resistance to heat-induced hemolysis (10) . IN-related red blood cell hemolysis has been reported in animal studies. Giglio and Bozzini (18) reported a transient decrease in hematocrit along with increased hemolysis in female mice receiving a single 400-jjLg dose of IN. IN has also been implicated, even if anecdotally, in the autoimmune form of hemolytic anemia in humans (15) .
The splenic cord mononuclear phagocytes play a major role in the removal of altered erythrocytes from the circulation (4) and have been shown to be able to detect red blood cells with only slight plasma membrane damage (20) . Drug-induced red cell membrane damage of a minor nature would first be detected by splenic RPM, which would remove these cells from the circulation. Continued red cell membrane damage would further activate other splenic RPMs and result in an increased cell population in the splenic cords, producing the increase in RPM grade we observed in our study. Kay (23) demonstrated an IgG autoantibody-binding antigen on senescent and damaged mammalian cells, which she feels is responsible for their removal from the circulation by macrophages. Other investigators have shown in in vitro studies that under certain pathologic conditions (e.g. favism, P. falciparum infection and sickle cell anemia) a CR-mediated mechanism may be responsible for elimination of damaged erythrocytes (3) . While a CR-mediated mechanism for removal of damaged erythrocytes cannot be ruled out in this study, work by Buckley et al (11) has demonstrated that more than 75% of splenic RPMs stain positively for F,R while less than 10% of these cells are positive for CR. Even though upregulation of CRs under pathologic conditions is a possibility, it is more likely that F,R-mediated phagocytosis is responsible for erythrocyte removal under normal conditions. In conclusion, the results of this study indicate that a complex interaction may be occurring with coadministration of E2 and IN. There is an apparent direct effect of both drugs on the splenic RPMs, with E2 producing a stimulatory effect (possibly regulating macrophage F,Rdependent clearance) and IN directly acting at least to partially inhibit (perhaps via downregulation of FcR-mediated phagocytosis) the effect of normophysiologic levels of estrogen. At the same time, both drugs may be icting on the red blood cell plasma membranes to change :heir fragility characteristics, prompting increased stimlation of the splenic RPMs to actively remove these Jamaged erythrocytes from the circulation, thereby low--ring hematocrit.
Although more needs to be done to further characterizẽ 2 and IN actions and interactions in the rabbit, we feel hat it potentially represents a useful in vivo model for evaluating the effect of estrogens and nonsteroidal antinflammatory drugs, alone and in combination, on the mmune system. Additional in vitro work is now under-way to assess the effects of both IN and E, on the membrane characteristics of rabbit erythrocytes. ACKNOWLEDGMENT Funding for this study was provided by a grant from the East Tennessee State University Research Development Committee.
